MOVE
Movano Inc.
MOVE offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
UNH
UnitedHealth Group Incorporated
UNH has the edge over MOVE overall, supported by stronger valuation.
MOVE Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
MOVE's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
MOVE PE Valuation
MOVE has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
MOVE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect MOVE's losses to shrink, with revenue growing.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
MOVE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$18.64 | +$10.13 |
| Q1 2026 | -$17.62 | +$16.05 |
| Q4 2025 | -$21.79 | +$19.58 |
| Q3 2025 | -$22.90 | +$25.20 |
| Q2 2025 | -$28.77 | +$35.73 |
| Q1 2025 | -$33.67 | +$47.33 |
| Q4 2024 | -$41.37 | +$53.13 |
| Q3 2024 | -$48.10 | +$67.40 |
MOVE is still losing money, but far less than before: $18.64 per share over the past year, against $227.31 at its worst in late 2021.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over MOVE on earnings quality, reporting a profit while its opponent remains loss making.
MOVE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5M | +6128% |
| Q2 2026 | $3.8M | +3590% |
| Q1 2026 | $510K | +148% |
| Q4 2025 | $44K | -60% |
| Q3 2025 | $80K | +60% |
| Q2 2025 | $103K | +348% |
| Q1 2025 | $206K | -76% |
MOVE's revenue is growing: $5M last quarter, up 6128% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -350% | +2889 points |
| Q2 2026 | -400% | +2765 points |
| Q1 2026 | -950% | +1592 points |
| Q4 2025 | -10032% | -5805 points |
| Q3 2025 | -3239% | +11519 points |
| Q2 2025 | -3165% | +24648 points |
| Q1 2025 | -2543% | -1867 points |
| Q4 2024 | -4227% | N/A |
MOVE's operating margin was −350% last quarter, up 2889 points from the same quarter a year ago, near the top of its range since 2024.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over MOVE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over MOVE on profitability, with a higher operating margin.
MOVE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$2.3M | +$2.3M |
| Q4 2024 | -$4.6M | +$702K |
| Q3 2024 | -$5.7M | +$1.3M |
| Q2 2024 | -$8.2M | -$262K |
| Q1 2024 | -$4.1M | +$2M |
| Q4 2023 | -$5.3M | +$1.1M |
| Q3 2023 | -$7M | -$517K |
| Q2 2023 | -$7.9M | -$1.5M |
UNH has the stronger cash trend. Its trailing FCF is up 5.2% versus its history, compared with MOVE at down 70%.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
MOVE Net Leverage
MOVE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
MOVE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.2 | Neutral |
| Stochastic | 1.9 | Oversold |
MOVE's weekly RSI is 36 (neutral) and its Stochastic is 2 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
MOVE PE vs Healthcare Sector
MOVE has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
MOVE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.27 | 43% below |
| 20 week MA | $11.0 | 57% below |
| 50 week MA | $12.7 | 63% below |
| 100 week MA | $16.0 | 70% below |
| 200 week MA | $66.2 | 93% below |
MOVE is in a downtrend: it's below all five of its weekly moving averages, and 93% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over MOVE on trend strength, trading above more of its moving averages.
MOVE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $846.0 | $447.0 | -47% |
| 2022 | $447.0 | $219.0 | -51% |
| 2023 | $219.0 | $117.2 | -46% |
| 2024 | $117.2 | $58.5 | -50% |
| 2025 | $58.5 | $8.14 | -86% |
| 2026 YTD | $8.14 | $4.71 | -42% |
MOVE has finished every year since 2021 lower, and it's down 42% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over MOVE on returns for 2026, with the stronger performance.